Form 4: Accuray Inc. Director Acquires Restricted Stock Units

Byron C Scott, a director at Accuray Inc., acquired 56,603 restricted stock units (RSUs) on November 29, 2024, which will vest on November 21, 2025.

Summary

• Byron C Scott, a director of Accuray Inc., has reported the acquisition of 56,603 restricted stock units (RSUs).
• The transaction occurred on November 29, 2024.
• Each RSU represents a contingent right to receive one share of Accuray's common stock.
• The RSUs will vest 100% on November 21, 2025.
• The acquisition was a direct transaction.

Sentiment

Score: 7

Explanation: The document reflects a standard insider transaction, which is generally positive as it aligns director interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.
• The vesting period of approximately one year could align the director's interests with the long-term success of the company.

Future Outlook

The RSUs will vest on November 21, 2025, at which point the director will receive shares of Accuray common stock.

Industry Context

This is a standard practice for companies to grant stock-based compensation to directors and executives to align their interests with shareholders.

Comparison to Industry Standards

• Stock-based compensation, such as RSUs, is a common practice among publicly traded companies, particularly in the technology and healthcare sectors, to incentivize and retain key personnel.
• Companies like Varian Medical Systems and Elekta, which are competitors of Accuray in the radiation oncology space, also utilize similar stock-based compensation plans for their directors and executives.
• The vesting period of approximately one year is also typical, aligning with standard industry practices for long-term incentive plans.

Stakeholder Impact

• The acquisition of RSUs by a director can be viewed positively by shareholders as it aligns the director's interests with the company's long-term performance.
• The vesting of the RSUs will increase the number of shares outstanding, which could have a minor dilutive effect on existing shareholders.

Next Steps

• The director will receive shares of Accuray common stock upon vesting of the RSUs on November 21, 2025.

Key Dates

Keywords

Accuray Inc, Restricted Stock Units, RSU, Director, Byron C Scott, Stock Acquisition, Insider Transaction